Aerosol Research and Engineering Laboratories, 13300 West 98th Street, Lenexa, Kansas 66215, USA.
Virol J. 2010 Jun 23;7:135. doi: 10.1186/1743-422X-7-135.
The routes by which humans acquire influenza H5N1 infections have not been fully elucidated. Based on the known biology of influenza viruses, four modes of transmission are most likely in humans: aerosol transmission, ingestion of undercooked contaminated infected poultry, transmission by large droplets and self-inoculation of the nasal mucosa by contaminated hands. In preparation of a study to resolve whether H5N1 viruses are transmissible by aerosol in an animal model that is a surrogate for humans, an inhalation exposure system for studies of aerosolized H5N1 viruses in ferrets was designed, assembled, and validated. Particular attention was paid towards system safety, efficacy of dissemination, the viability of aerosolized virus, and sampling methodology.
An aerosol generation and delivery system, referred to as a Nose-Only Bioaerosol Exposure System (NBIES), was assembled and function tested. The NBIES passed all safety tests, met expected engineering parameters, required relatively small quantities of material to obtain the desired aerosol concentrations of influenza virus, and delivered doses with high-efficacy. Ferrets withstood a mock exposure trial without signs of stress.
The NBIES delivers doses of aerosolized influenza viruses with high efficacy, and uses less starting material than other similar designs. Influenza H5N1 and H3N2 viruses remain stable under the conditions used for aerosol generation and sample collection. The NBIES is qualified for studies of aerosolized H5N1 virus.
人类感染 H5N1 流感的途径尚未完全阐明。根据流感病毒的已知生物学特性,人类最有可能通过以下四种途径传播:气溶胶传播、摄入未煮熟的受感染家禽、大飞沫传播和受污染的手自我接种鼻腔黏膜。为了研究 H5N1 病毒是否可以在一种模拟人类的动物模型中通过气溶胶传播,设计、组装和验证了一种用于研究 H5N1 病毒气溶胶化的雪貂吸入暴露系统。特别注意了系统安全性、传播效率、气溶胶化病毒的生存能力和采样方法。
组装并功能测试了一种称为仅鼻腔生物气溶胶暴露系统(NBIES)的气溶胶生成和输送系统。NBIES 通过了所有安全测试,满足预期的工程参数要求,仅需少量材料即可获得所需的流感病毒气溶胶浓度,并具有高效的输送剂量。雪貂经受住了模拟暴露试验而没有出现应激迹象。
NBIES 以高效的方式输送气溶胶化流感病毒剂量,并且使用的起始材料比其他类似设计少。在用于气溶胶生成和样品采集的条件下,H5N1 和 H3N2 流感病毒保持稳定。NBIES 有资格进行 H5N1 病毒气溶胶化研究。